Most Recent
A judge has issued an injunction temporarily barring use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a “disturbing” number of similarities with the marketing and appearance of an established competitor’s Rescue natural sleep aid product.
Victorian public healthcare provider Peninsula Health has been hit with a class action brought by junior doctors who claim they were deliberately unpaid despite working a significant amount of overtime each week.
Women's activewear company Lorna Jane has defended ACCC allegations that it represented to consumers during that height of the coronavirus pandemic that its activewear would protect them from viruses including COVID-19, saying it had a reasonable and proper basis for making the claims.
Swiss drug giant Novartis has sued generic drug maker Pharmacor to halt its launch of a generic version of the company's top-selling MS drug Gilenya.
Generic pharmaceutical company Sandoz has hit back in an intellectual property lawsuit by Merck Sharp & Dohme, filing a cross-claim that seeks to undo an extension of time granted to the US drug manufacturer for a patent relating to its multibillion dollar Januvia and Janumet diabetes drugs.
The Full Federal Court has tossed an appeal by Johnson & Johnson unit Ethicon challenging a landmark decision that put it on the hook for paying damages to 10,000 women who suffered injury through defects in its prolapse mesh and incontinence tape implants.
Medical device giant Boston Scientific faces a class action on behalf of women who allege they suffered debilitating injuries from the company's pelvic mesh products.
More than half of the $37.75 million settlement reached in a shareholder class action against aged care provider Estia Health will be left for distribution to group members if the settlement is approved at an upcoming hearing.
Pelvic mesh device maker Astora Women's Health is weighing whether to make admissions in a class action over allegedly defective products in light of a similar, high profile class action brought against Johnson & Johnson unit Ethicon over the devices.
Fertility clinic Monash IVF says there are "serious questions" about whether a class action that accuses it of destroying viable embryos was validly commenced as a class action.